Application and progress of resuscitative endovascular balloon occlusion of the aorta(REBOA) in early anti-shock therapy
10.3760/cma.j.cn112434-20200404-00190
- VernacularTitle:复苏性主动脉腔内球囊阻断术在早期抗休克治疗中的应用及进展
- Author:
Hao ZHANG
1
;
Qingsheng LU
Author Information
1. 中国人民解放军海军军医大学附属长海医院血管外科，上海 200433
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(10):637-640
- CountryChina
- Language:Chinese
-
Abstract:
Resuscitative endovascular balloon occlusion of the aorta(REBOA) is an important technical method for early anti-shock. It can quickly achieve effective hemostasis, maintain basic blood pressure, ensure blood supply to important organs such as the brain, and improve the success rate of anti-shock treatment. However, the use of REBOA is limited because it can cause complications such as severe distal ischemia. With the improvement of clinical awareness and the continuous improvement of anti-shock treatment concept, REBOA has made significant progress, including the use of pREBOA and iREBOA, and the use in cardiac arrest. In order to make better use of REBOA, further in-depth research is needed to establish a comprehensive medical treatment system and training system to maximize its role.
